Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference63 articles.
1. Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab.;Topalian;J Clin Oncol,2014
2. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.;Topalian;N Engl J Med,2012
3. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.;Hamid;N Engl J Med,2013
4. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.;Brahmer;N Engl J Med,2012
5. A study of MPDL3280A, an engineered PD-L1 antibody in patients with locally advanced or metastatic tumors.;Herbst;J Clin Oncol,2013
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献